|
|
Post by kball on Jan 26, 2016 15:28:17 GMT -5
Just spitballin' here but is everyone ok with a 1 for 1 in Berkshire A shares?
(Apologies to Warren as i feel i must)
|
|
|
|
Post by dreamboatcruise on Jan 26, 2016 15:28:41 GMT -5
Good point about BK risk factor on current sp. Pretty much all depends on what Al will accept. I don't think $3-$4 billion is out of the realm of possibility for the whole enchilada, but is definitely ambitious for Afrezza at this point. One thing is certain, big/ smart money will know before we do and the sp will react accordingly... Being little/dumb money, I fully appreciate this last statement. Though the $3B seems quite a stretch where we are now. |
|
|
|
Post by saxcmann on Jan 26, 2016 15:29:06 GMT -5
while i agree with you, i don't believe a company will come in and buy Mannkind right now anywhere near what we all think it's worth in the long run. Would you be willing to accept an offer under a billion? If MNKD is sold, it's because our hand was forced and not because Al Mann wanted it. Under a billion is laughable...never will happen. |
|
|
|
Post by nemzter on Jan 26, 2016 15:29:37 GMT -5
Hmm, makes me wonder how much the NOLs would be worth in this scenario. A buyout would destroy their value, wouldn't it? I'm of the opinion that there will be some sort of share swap to keep them intact for the buyer.
$5/share anyone?
|
|
|
|
Post by nemzter on Jan 26, 2016 15:31:33 GMT -5
while i agree with you, i don't believe a company will come in and buy Mannkind right now anywhere near what we all think it's worth in the long run. Would you be willing to accept an offer under a billion? If MNKD is sold, it's because our hand was forced and not because Al Mann wanted it. Under a billion is laughable...never will happen. Never say never... I mean, look a the share price now, anything is a possibility at this moment. |
|
|
|
Post by harryx1 on Jan 26, 2016 15:35:17 GMT -5
Doesn't posting complete articles from newspapers, magazines, and news agencies such as Reuters violate copyright laws? Links are OK, as are brief quotes, but not complete articles. Stock manipulation is illegal also and we've all seen how that is enforced.  |
|
|
|
Post by rvc on Jan 26, 2016 15:36:10 GMT -5
it can't be good news for most long term holders. There is no way MNKD gets a premium offer given the current pps and precarious state of their fiscal affairs. Given that, it's not surprising that someone would come in now and give a lowball offer. My guess would be the offer price before SNY bailed-mid to high 1's.
|
|
|
|
Post by seanismorris on Jan 26, 2016 15:37:07 GMT -5
This is FUD.
The quote is "Mannkind is working with investment bankers on options".
That doesn't mean the company is up for sale. Matt would be crazy to not explore all the options for raising funds.
But, anyone thinking Al wants out has a greater than 99% chance of being wrong.
This isn't an "article" this its a rumor.
|
|
|
|
Post by compound26 on Jan 26, 2016 15:38:25 GMT -5
I believe Al personally invested about $1 billion into Mannkind (and 10+ years of his life and hard word). He would expect to at least recover his investment. Since Al now owes 40% of Mannkind, I would expect Al to be willing to consider offers of $2.5 billion (and above) for the whole company (around $5/6 per share, considering the current shares outstanding and the existing loans).
Admittedly, Mannkind is not in a great position financially, but there are certainly options for Al and Mannkind to get the funds to sustain the operation till the end of 2017. Therefore, if there are no reasonably acceptable offers as described above, I would think Mannkind still could opt to pursue the marketing strategy Matt outlined in the JPM presentation.
|
|
|
|
Post by rvc on Jan 26, 2016 15:38:51 GMT -5
How could this possibly be good news for longs at the current pps levels...? What a company could/would reasonably pay for MNKD is not going to be what it would have been a year ago for sure. But, the share price of a company does factor in risk. A reasonable argument could be made that there is significant bankruptcy risk factored into the trading price. An acquirer would be buying on value of company without that risk factor built in. The trading price causes difficulties for MNKD in negotiations, but if a company acquires MNKD they will need to argue to their shareholders that Afrezza has value and market potential, and if they do that they certainly could justify more than $1 even if Afrezza were to only get a small slice of prandial market. How much more than $1 could be negotiated successfully by MNKD, and justified to shareholders by the acquirer (assuming it were public) is another question... I doubt it would be $7.5 as someone above is wishing for. |
|
|
|
Post by nemzter on Jan 26, 2016 15:42:15 GMT -5
What's even more sad is mgmt did absolutely NOTHING about this. MM's 1 MNKD 0 |
|
|
|
Post by kc on Jan 26, 2016 15:42:58 GMT -5
Selling the company at these depressed levels could be quite frightening. I wonder what the minimum we could get per share would be? What do you all think the maximum would be too? I would not worry about what the value is today. The inherit value of MannKind is a minimum of $12.00 per share. If the company is putting itself up for sale there will be a bidding war as big Pharm understands what the value of Afrezza is long term. I'm surprised this has not occurred yet. It just takes a low ball offer to get the company in play. Don't be surprised if there are already several big Pharma companies that hold 4.99% of MannKind's shares. They can accumulate them without reporting and I'm sure somebody has been doing that for months if not years. A pharma could have hired one or multiple shill companies to buy shares and hold them. So say for instance Novo hired JP Morgan and they bought 4.99% quietly and then another investment banker or two collecting 4.99% they could own many shares in a dark pool and then make an offer to buy the company. Games are played everyday on wall street. Uncle Bob works for JP Morgan and tells his cousin Bill to buy some shares and then you have game on.
Love to see it happen sooner than later so that Afrezza has a chance to make it in the marketplace and give Diabetics a better life. It will happen sooner or later.
|
|
|
|
Post by suebeeee1 on Jan 26, 2016 15:42:56 GMT -5
Doesn't posting complete articles from newspapers, magazines, and news agencies such as Reuters violate copyright laws? Links are OK, as are brief quotes, but not complete articles. Sorry, you are correct. I have removed the text and left the title and link. |
|
|
|
Post by madog365 on Jan 26, 2016 15:43:39 GMT -5
I am hoping Mannkind addresses this rumor immediately. I personally believe this speculation is completely false and goes against everything Matt said at the JPM conference.
|
|
|
|
Post by cgiscgis on Jan 26, 2016 15:44:58 GMT -5
The biggest question nobody asked: Who leaked this after the boardroom meeting and why?
|
|
